Worth a shot? The economics of the race for a vaccine:
Avalia's CEO Dr Shivali Gulab shares insights into the economics of COVID-19 vaccine development efforts alongside Associate Professor Helen Petousis-Harris,…
Dr Kronenberg, elected distinguished fellow by AAI:
Avalia's newly appointed director, Dr Mitch Kronenberg, receives highest honour for his outstanding scientific contributions to the field of immunology
Avalia's founding CSO and head of cancer immunotherapy at Malaghan Institute of Medical Research, Professor Ian Hermans, discusses the developing field…
New Wellington company to develop potential treatment for treating cancer:
An immunotherapy technology for treating cancer and other diseases, jointly developed by Victoria University of Wellington’s Ferrier Research Institute and…